Technical Analysis for CWBR - CohBar, Inc

Grade Last Price % Change Price Change
grade F 1.35 -8.16% -0.1200
CWBR closed down 8.16 percent on Monday, September 9, 2019, on 12 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical CWBR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
New 52 Week Closing Low Bearish -8.16%
Hammer Candlestick Bullish -8.16%
Hot IPO Pullback Bullish Swing Setup -8.16%

Older signals for CWBR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. The company focuses on the development of mitochondrial-derived peptides (MDPs) into clinically relevant MBTs that offer the potential to address a range of age-related diseases with underlying metabolic dysfunction, including nonalcoholic steatohepatitis (NASH), obesity, type 2 diabetes, cancer, and cardiovascular and neurodegenerative diseases. Its lead program is based on CB4211, a mitochondria based therapeutic for nonalcoholic steatohepatitis (NASH) and obesity. CohBar, Inc. was founded in 2007 and is headquartered in Menlo Park, California.
Medicine Biotechnology Medical Specialties Cancer Diabetes Organ Systems Obesity Hepatitis Stage Biotechnology Metabolic Syndrome Steatohepatitis Cardiovascular And Neurodegenerative Diseases Neurodegeneration Non Alcoholic Fatty Liver Disease
Is CWBR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 1.35
Average Volume 65,777
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 3.3
Average True Range 0.9186
ADX 0.0
+DI 10.4339
-DI 50.7496
Chandelier Exit (Long, 3 ATRs ) 6.4942
Chandelier Exit (Short, 3 ATRs ) 4.1058
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line -0.6564
MACD Signal Line -0.2436
MACD Histogram -0.4128
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.4700
Resistance 3 (R3) 1.4833 1.4567 1.4500
Resistance 2 (R2) 1.4567 1.4261 1.4500 1.4433
Resistance 1 (R1) 1.4033 1.4072 1.3900 1.3900 1.4367
Pivot Point 1.3767 1.3767 1.3700 1.3700 1.3767
Support 1 (S1) 1.3233 1.3461 1.3100 1.3100 1.2633
Support 2 (S2) 1.2967 1.3272 1.2900 1.2567
Support 3 (S3) 1.2433 1.2967 1.2500
Support 4 (S4) 1.2300